See also this year's filing and all EDGAR filings for this company.
PDF Report 0001016504_2024_Integrated_Biopharma_INC.pdf
Logs
Graph
Absolute values for 0001016504, Integrated Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 16,372,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,653,000 |
| 3 | remainder_Assets | 7,406,000 |
| 4 | LiabilitiesCurrent | 4,828,000 |
| 5 | LiabilitiesNoncurrent | 1,735,000 |
| 6 | remainder_Liabilities | 7,000 |
| 7 | CostOfGoodsAndServicesSold | 46,718,333 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,928,779 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 28,728 |
| 11 | remainder_Revenues | 51,039,659 |
| 12 | remainder_NetIncome | -43,182 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 25,431,000 |
| 1 | Liabilities | 6,570,000 |
| 2 | Expenses | 50,675,840 |
| 3 | Revenues | 51,039,659 |
| 4 | StockholdersEquity | 18,861,000 |
| 5 | NetIncome | 320,637 |
| 6 | ComprehensiveNetIncome | 320,637 |
| 7 | BaseVar | 66,879,840 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.59 |
| 9 | EconomicCapitalRatio | 3.41 |